Try our mobile app

Lilly Shares Positive Donanemab Data in First Active Comparator Study in Early Symptomatic Alzheimer's Disease

Published: 2022-11-30 23:00:00 ET
<<<  go to LLY company page

- Brain amyloid clearance (